PROTEOMICS INTERNATIONAL LABORATORIES LTD - Announcements

0.00%

38.0¢

Market Cap $62.19M

Healthcare Biotechnology

Proteomics International Laboratories Ltd is an Australia-based medical technology... Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bioanalytical services. It specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. It focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identified up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PIQ	Letter to Eligible Shareholders - Entitlement Issue		15/09/15	294.59KB	Share
PIQ	Non-renounceable Pro-rata Options Entitlement Issue	PRICE SENSITIVE	14/09/15	99.14KB	Share
PIQ	Letter to option holders - Entitlement Issue		11/09/15	238.08KB	Share
PIQ	Appendix 3B - Entitlement Issue		11/09/15	90.26KB	Share
PIQ	Entitlement Issue Prospectus	PRICE SENSITIVE	11/09/15	349.25KB	Share
PIQ	Investor Presentation - September 2015		02/09/15	992.28KB	Share
PIQ	Preliminary Final Report	PRICE SENSITIVE	31/08/15	425.17KB	Share
PIQ	Investor Presentation - August 2015		19/08/15	814.74KB	Share
PIQ	Appendix 4C - June 2015 Quarterly Report	PRICE SENSITIVE	31/07/15	165.29KB	Share
PIQ	Appendix 3B - Release from escrow		30/06/15	79.67KB	Share
PIQ	Appendix 3B - Release from escrow		23/06/15	79.7KB	Share
PIQ	Release from escrow		16/06/15	52.63KB	Share
PIQ	Investor Presentation - June 2015		10/06/15	699.86KB	Share
PIQ	Release from escrow		09/06/15	52.65KB	Share
PIQ	Ground-breaking Predictive Test for Diabetic Kidney Disease	PRICE SENSITIVE	09/06/15	153.47KB	Share
PIQ	Appendix 3B - Release from escrow		05/06/15	82.35KB	Share
PIQ	Release from escrow		22/05/15	52.65KB	Share
PIQ	Diagnostic Test Patent Accepted for Diabetic Kidney Disease	PRICE SENSITIVE	21/05/15	148.63KB	Share
PIQ	Proteomics appoints Global Head of Business Development		19/05/15	158.46KB	Share
PIQ	Appendix 3B - Release from escrow		12/05/15	79.56KB	Share
PIQ	Appendix 3B - Release from escrow		06/05/15	79.52KB	Share
PIQ	Release from escrow		28/04/15	62.78KB	Share
PIQ	Proteomics secures major contract in Bio-similars market	PRICE SENSITIVE	28/04/15	155.66KB	Share
PIQ	Proteomics secures major contract with The a2 Milk Company	PRICE SENSITIVE	23/04/15	157.63KB	Share
PIQ	Becoming a substantial holder		21/04/15	211.18KB	Share
PIQ	Release from escrow		20/04/15	52.63KB	Share
PIQ	Becoming a substantial holder		20/04/15	61.55KB	Share
PIQ	Becoming a substantial holder		20/04/15	64.27KB	Share
PIQ	Proteomics International Laboratories to list on ASX today		16/04/15	113.27KB	Share
PIQ	Initial Directors' Interest Notices		15/04/15	56.18KB	Share
PIQ	Securities Trading Policy		14/04/15	49.29KB	Share
PIQ	Corporate Governance Statement		14/04/15	88.56KB	Share
PIQ	Terms and conditions of performance rights		14/04/15	17.19KB	Share
PIQ	Accounts for Proteomics International Pty Ltd (2012-2014)		14/04/15	385.8KB	Share
PIQ	Constitution		14/04/15	419.42KB	Share
PIQ	Appendix 1A and Information Form & Checklist		14/04/15	121.89KB	Share
PIQ	Pre-quotation announcement		14/04/15	141.97KB	Share
PIQ	Pre-quotation disclosure		14/04/15	89.4KB	Share
PIQ	ASX Notice		14/04/15	147.68KB	Share
PIQ	Admission to official list	PRICE SENSITIVE	14/04/15	80.37KB	Share
PIQ	Successfully Closes IPO		07/04/15	116.17KB	Share
PIQ	Second Supplementary Prospectus		24/02/15	144.87KB	Share
PIQ	Supplementary Prospectus		27/01/15	53.05KB	Share
PIQ	Proteomics International Laboratories Ltd - Prospectus		10/11/14	1.54MB	Share

PIQ Letter to Eligible Shareholders - Entitlement Issue
15/09/15		294.59KB	Share
PIQ Non-renounceable Pro-rata Options Entitlement Issue
14/09/15	PRICE SENSITIVE	99.14KB	Share
PIQ Letter to option holders - Entitlement Issue
11/09/15		238.08KB	Share
PIQ Appendix 3B - Entitlement Issue
11/09/15		90.26KB	Share
PIQ Entitlement Issue Prospectus
11/09/15	PRICE SENSITIVE	349.25KB	Share
PIQ Investor Presentation - September 2015
02/09/15		992.28KB	Share
PIQ Preliminary Final Report
31/08/15	PRICE SENSITIVE	425.17KB	Share
PIQ Investor Presentation - August 2015
19/08/15		814.74KB	Share
PIQ Appendix 4C - June 2015 Quarterly Report
31/07/15	PRICE SENSITIVE	165.29KB	Share
PIQ Appendix 3B - Release from escrow
30/06/15		79.67KB	Share
PIQ Appendix 3B - Release from escrow
23/06/15		79.7KB	Share
PIQ Release from escrow
16/06/15		52.63KB	Share
PIQ Investor Presentation - June 2015
10/06/15		699.86KB	Share
PIQ Release from escrow
09/06/15		52.65KB	Share
PIQ Ground-breaking Predictive Test for Diabetic Kidney Disease
09/06/15	PRICE SENSITIVE	153.47KB	Share
PIQ Appendix 3B - Release from escrow
05/06/15		82.35KB	Share
PIQ Release from escrow
22/05/15		52.65KB	Share
PIQ Diagnostic Test Patent Accepted for Diabetic Kidney Disease
21/05/15	PRICE SENSITIVE	148.63KB	Share
PIQ Proteomics appoints Global Head of Business Development
19/05/15		158.46KB	Share
PIQ Appendix 3B - Release from escrow
12/05/15		79.56KB	Share
PIQ Appendix 3B - Release from escrow
06/05/15		79.52KB	Share
PIQ Release from escrow
28/04/15		62.78KB	Share
PIQ Proteomics secures major contract in Bio-similars market
28/04/15	PRICE SENSITIVE	155.66KB	Share
PIQ Proteomics secures major contract with The a2 Milk Company
23/04/15	PRICE SENSITIVE	157.63KB	Share
PIQ Becoming a substantial holder
21/04/15		211.18KB	Share
PIQ Release from escrow
20/04/15		52.63KB	Share
PIQ Becoming a substantial holder
20/04/15		61.55KB	Share
PIQ Becoming a substantial holder
20/04/15		64.27KB	Share
PIQ Proteomics International Laboratories to list on ASX today
16/04/15		113.27KB	Share
PIQ Initial Directors' Interest Notices
15/04/15		56.18KB	Share
PIQ Securities Trading Policy
14/04/15		49.29KB	Share
PIQ Corporate Governance Statement
14/04/15		88.56KB	Share
PIQ Terms and conditions of performance rights
14/04/15		17.19KB	Share
PIQ Accounts for Proteomics International Pty Ltd (2012-2014)
14/04/15		385.8KB	Share
PIQ Constitution
14/04/15		419.42KB	Share
PIQ Appendix 1A and Information Form & Checklist
14/04/15		121.89KB	Share
PIQ Pre-quotation announcement
14/04/15		141.97KB	Share
PIQ Pre-quotation disclosure
14/04/15		89.4KB	Share
PIQ ASX Notice
14/04/15		147.68KB	Share
PIQ Admission to official list
14/04/15	PRICE SENSITIVE	80.37KB	Share
PIQ Successfully Closes IPO
07/04/15		116.17KB	Share
PIQ Second Supplementary Prospectus
24/02/15		144.87KB	Share
PIQ Supplementary Prospectus
27/01/15		53.05KB	Share
PIQ Proteomics International Laboratories Ltd - Prospectus
10/11/14		1.54MB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 38.0¢		Change 0.000(0.00%)		Mkt cap ! $62.19M

Open	High	Low	Value	Volume
39.0¢	40.0¢	38.0¢	$58.62K	150.4K

Buyers (Bids)

No.	Vol.	Price($)
2	12180	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
38.5¢	5203	1

View Market Depth

No.	Vol.	Price($)
2	12180	0.370
1	36	0.360
2	31937	0.355
2	6428	0.350
1	2898	0.345

Price($)	Vol.	No.
0.385	5203	1
0.400	26318	4
0.410	100000	1
0.425	2775	1
0.440	1983	1

Last trade - 15.42pm 08/08/2025 (20 minute delay)

PIQ (ASX) Chart

PROTEOMICS INTERNATIONAL LABORATORIES LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available